We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Illumina Inc (ILMN) Com Stk Usd0.01

Sell:$147.59 Buy:$147.66 Change: $4.84 (3.19%)
NASDAQ:0.09%
Market closed |  Prices as at close on 12 November 2024 | Switch to live prices |
Sell:$147.59
Buy:$147.66
Change: $4.84 (3.19%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 12 November 2024 | Switch to live prices |
Sell:$147.59
Buy:$147.66
Change: $4.84 (3.19%)
Market closed |  Prices as at close on 12 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.

Contact details

Address:
5200 Illumina Way
SAN DIEGO
92122-4616
United States
Telephone:
+1 (858) 2024500
Website:
https://www.illumina.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ILMN
ISIN:
US4523271090
Market cap:
$24.03 billion
Shares in issue:
159.00 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Jacob Thaysen
    Chief Executive Officer, Director
  • Ankur Dhingra
    Chief Financial Officer
  • Patricia Leckman
    Chief People Officer
  • Steve Barnard
    Chief Technology Officer
  • Carissa Rollins
    Chief Information Officer
  • Scott Davies
    Interim General Counsel and Secretary
  • Everett Cunningham
    Chief Commercial Officer
  • Kevin Pegels
    Chief of Global Operations
  • Jakob Wedel
    Chief Strategy and Corporate Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.